The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: A review

Advances in Anatomic Pathology

Volumn 10, Issue 1, 2003, Pages 39-43

  Lamps, Laura W ^a   Folpe, Andrew L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Cholangiocarcinoma; Hepatoblastoma; Hepatocellular carcinoma; Hepatocyte paraffin 1; Immunohistochemistry

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR MARKER;

BILE DUCT CARCINOMA; BILE DUCT TUMOR; DIFFERENTIAL DIAGNOSIS; HEPATOBLASTOMA; HUMAN; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; REVIEW;

ANTIBODIES, MONOCLONAL; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; HEPATOBLASTOMA; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0242539445     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200301000-00004     Document Type: Review

References (25)

1. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber- EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Path 1990;43:213-219. (Pubitemid 20087572)
2. Ma CK, Zarbo RJ, Frierson HF Jr., Lee MW. Comparative immunohistochemical study of primary and metastatic carcinomas of the live [see comments]. Am J Clin Path 1993;99:551-557. (Pubitemid 23154095)
3. Rishi M, Kovatich A, Ehya H. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates. Diag Cytopath 1994;11:358-361; discussion 361-362.
4. Oliveira AM, Erickson LA, Burgart LJ, Lloyd RV. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA [see comments]. Am J Surg Path 2000;24:177-182. (Pubitemid 30078705)
5. Porcell AI, DeYoung BR, Proca DM, Frankel WL. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Path 2000;13:773-778. (Pubitemid 30470167)
6. Yaziji H, Gown AM. Is albumin mRNA detection in the diagnosis of hepatocellular carcinoma better than existing markers? [letter; comment]. Am J Surg Path 2000;24:1177-1179. (Pubitemid 30612846)
7. Hurlimann J, Gardiol D. Immunohistochemistry in the differential diagnosis of liver carcinomas [see comments]. Am J Surg Path 1991;15:280-288.
8. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepaticellular carcinoma from cholangiocarcinoma, combined tumors and metastatic carcinoma. Histopathology 1998;33:318-324. (Pubitemid 28508880)
9. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. App Immunohistochem 1995;3:99-107.
10. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Path 2000;13:962-972.
11. Yamaguchi K, Nalesnik MA, Carr BI. In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin. Virchows Archiv. B, Cell Pathology Including Molecular Pathology 1993;64:361-365.
12. Krishna M, Lloyd RV, Batts KP. Detection of albumin messenger RNA in hepatic and extrahepatic neoplasms. A marker of hepatocellular differentiation. Am J Surg Path 1997;21:147-152. (Pubitemid 27084053)
13. Murray GI, Paterson PJ, Ewen SW, Melvin WT. In situ hybridization of albumin mRNA in normal liver and hepatocellular carcinoma with a digoxigenin labeled oligonucleotide probe. J Clin Path 1992;45:21-24.
14. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Path 1993; 143:1050-1054. (Pubitemid 24070547)
15. Fasano M, Theise ND, Nalesnik M, et al. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific-marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol 1998;11:934-938.
16. Zimmerman RL, Burke MA, Young NA, Solomides CC, Bibbo M. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-291. (Pubitemid 32777535)
17. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte- specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-692. (Pubitemid 27321760)
18. Murakata LA, Ishak KG, Nzeako UC. Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 2000;13:874-881. (Pubitemid 30643835)
19. Wu PC, Fang JW, Lau VK, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Path 1996; 149:1167-1175. (Pubitemid 26337236)
20. Kumagai I, Masuda T, Sato S, Ishiwaka K. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histologic pattern. Hepatology Research 2001;20:312-319. (Pubitemid 32573893)
21. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma. An immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Path 2002;28:978-988. (Pubitemid 34810558)
22. Muir T, Kakar S, Murphy L, Roche P, Burgart L. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatic and extrahepatic tumors. Mod Pathol 2002;15:290A.
23. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol 2001;115:689-694. (Pubitemid 33051535)
24. Fan Z, van de Rijn M, Rouse R. HepPar-1 stain for the differential diagnosis of hepatocellular carcinoma: 613 tumors tested using tissue micro-arrays and conventional sections. Mod Pathol 2002; 15:1178A.
25. Pitman M, Triratanachat S, Young R, Oliva E. Hepatocyte paraffin 1 antibody cannot distinguish primary ovarian malignancies with hepatoid differentiation from metastatic hepatocellular carcinoma. Mod Pathol 2002;15:206A.